NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/06/2026
Back to search
Official data from USPTO
SYNTHON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SYNTHON
ST13
US500000087464096Class
5, 35, 40, 45
Filing
87464096
Registration
5923742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
04/07/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 35, 40, 45
Filing date
05/25/2017
Registration date
12/03/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2026
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
CM NIJMEGEN, NL
Examiner
AYALA, LOURDES
Current location
Historical data usage
Holders and representatives
Holders
SYNTHON B.V.
Synthon Holding B.V.
Representatives
E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC
Technical classification
Nice Classes
Class 5Class 35Class 40Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
PHARMACEUTICAL PREPARATIONSSUBSTANCES AND COMPOSITIONS FOR THE TREATMENT OF CANCERMULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEMNEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERSCARDIOVASCULAR DISORDERSMETABOLIC AND GASTRIC DISORDERSBLOOD DISORDERSBONE DISORDERSHORMONAL DISORDERSTREATMENT OF PAINFUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIA; BIOLOGICAL AND BIOCHEMICAL DRUG AND CULTURES FOR MEDICAL USEBIOLOGICAL TISSUE CULTURES FOR MEDICAL PURPOSES; CULTURE FLUIDS FOR CULTIVATING HUMANANIMAL CELLS AND PLANTSPLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR CULTIVATING HUMANANIMAL CELLS AND PLANTSPLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR USE IN CULTURING EUKARYOTIC CELLS; PHARMACEUTICAL BIOLOGICAL AND BIOCHEMICAL DRUGS FOR THE TREATMENT OF NEOPLASMS AND AUTOIMMUNE DISEASE
Class 35
OFFICE FUNCTIONS RELATING TO THE REGISTRATION OF PHARMACEUTICAL PREPARATIONS AND COMPONENTS AND PHARMACEUTICAL DRUGS; OFFICE FUNCTIONS RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; BUSINESS MEDIATION OF AGREEMENTS REGARDING THE PURCHASESALE AND LICENSING OF PHARMACEUTICAL REGISTRATIONS AND PHARMACEUTICAL REGISTRATION DOSSIERS; BUSINESS ADVICE AND INFORMATION; BUSINESS CONSULTATION; PROCUREMENT OF CONTRACTS FOR OTHERS FOR THE PURCHASE AND SALE OF GOODS; BUSINESS SERVICESCOMPILING OF PHARMACEUTICAL REGISTRATION DOSSIERS FOR OTHERS
Class 40
TREATMENT OF MATERIALS FOR THE MANUFACTURE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS; MANUFACTUREFOR OTHERSOF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS AND RAW MATERIALS FOR THE PHARMACEUTICAL INDUSTRYALL IN THE FIELD OF TREATMENT OF CANCERMULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEMNEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERSCARDIOVASCULAR DISORDERSMETABOLIC AND GASTRIC DISORDERSBLOOD DISORDERSBONE DISORDERSHORMONAL DISORDERSTREATMENT OF PAINFUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIA
Class 45
LEGAL SERVICES RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; PROVIDING LEGAL SERVICES AND INFORMATION IN THE FIELD OF INTELLECTUAL PROPERTY; LEGAL ADVICE IN THE FIELD OF INTELLECTUAL PROPERTY
Publications
History of USPTO decisions and trademark events.
47 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2026
ES8R
TEAS SECTION 8 RECEIVED
11/21/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/21/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2019
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/30/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/30/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/23/2019
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/17/2019
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/17/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/16/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2019
PUBO
PUBLISHED FOR OPPOSITION
07/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2019
ALIE
ASSIGNED TO LIE
06/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/21/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/21/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/21/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/21/2019
EXPT
EXPARTE APPEAL TERMINATED
05/02/2019
EXAR
EXPARTE APPEAL AFFIRMED/REVERSED IN PART
02/14/2019
GNSN
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
07/20/2018
GNES
EXAMINERS STATEMENT E-MAILED
07/20/2018
CNES
EXAMINERS STATEMENT - COMPLETED
07/20/2018
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/31/2018
EXPI
EX PARTE APPEAL-INSTITUTED
03/23/2018
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/23/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/25/2018
GNFR
FINAL REFUSAL E-MAILED
01/25/2018
CNFR
FINAL REFUSAL WRITTEN
01/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/22/2017
GNRT
NON-FINAL ACTION E-MAILED
06/22/2017
CNRT
NON-FINAL ACTION WRITTEN
06/22/2017
DOCK
ASSIGNED TO EXAMINER
06/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2017
NWAP
NEW APPLICATION ENTERED
05/29/2017
Continuous trademark protection
Get notified about every new filing that threatens SYNTHON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.